You are here

  • Home
  • Archive
  • Volume 5, Issue 4
  • Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure

Article Text

Article menu
Download PDFPDF
Ischemic stroke
Original research
Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure
  1. Edgar A Samaniego1,2,
  2. Francesca Tari-Capone3,
  3. Italo Linfante1,2,
  4. Christine F Silva4,
  5. Gabriela Spilberg4,
  6. Matthew Gounis4,
  7. Ajay K Wakhloo4,
  8. Guilherme Dabus1,2
  1. 1Department of Neurointerventional Surgery, Baptist Cardiac and Vascular Institute, Miami, FL, USA
  2. 2Department of Neurointerventional Surgery, Baptist Neuroscience Center, Miami, FL, USA
  3. 3Department of Neuroscience, Mental Health and Sensory Organs, University of Rome ‘La Sapienza’, Rome, Italy
  4. 4Department of Radiology, New England Center for Stroke Research, University of Massachusetts Medical School, Worcester, MA, USA
  1. Correspondence to Dr G Dabus, Department of Neurointerventional Surgery, Baptist Cardiac and Vascular Institute, 8900 N Kendall Drive, Miami 33156, Florida, USA; gdabus{at}gmail.com

Abstract

Background and purpose Intracranial stenting with the Wingspan system has been used as a revascularization strategy in symptomatic patients with intracranial atherosclerotic disease (ICAD). The latest results of the Stenting versus Aggressive Medical Therapy for Intracranial Artery Stenosis (SAMMPRIS) trial challenge this approach. Our experience in the treatment of symptomatic ICAD with the Wingspan system is reported.

Materials and methods Patients who underwent stenting for symptomatic ICAD were included in the analysis. Demographic data, periprocedural complications, long term radiological and clinical outcomes are reported.

Results 46 lesions were treated in 45 patients. 13 patients (29%) presented with a transient ischemic attack and 32 (71%) with a stroke. 43 patients (95.5%) failed antithrombotic therapy at presentation. One (2%) symptomatic periprocedural (24 h) complication occurred. The 30 day incidence of stroke and vascular death was 6.6%—a fatal hemorrhagic stroke and two non-fatal hemorrhagic strokes. In-stent stenosis (≥50%) was seen in nine (42.8%) lesions, two were symptomatic.

Conclusions This cohort of patients with symptomatic ICAD who failed antithrombotic medications benefited from angioplasty and stenting with the Wingspan system.

https://doi.org/10.1136/neurintsurg-2012-010321

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Ethics approval Ethics approval was provided by the institutional review board committee.

    • Provenance and peer review Not commissioned; not externally peer reviewed.